StockAnalyst
/
Electra Therapeutics targets $977.6 million valuation in US IPO

Electra Therapeutics targets $977.6 million valuation in US IPO

来源：Reuters发布于 2026-09-14

Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in ​its U.S. initial public offering, according ‌to a filing on Monday, extending a comeback in biotech listings th...

相关标的：ETRA
继续访问返回新闻

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。